{"database": "lobbying", "table": "lobbying_activities", "rows": [[1441929, "b2e141c3-6151-4a71-af7c-982a6398edd8", "Q3", "GREATER NEW YORK HOSPITAL ASSOCIATION", 16830, "GREATER NEW YORK HOSPITAL ASSOCIATION", 2013, "third_quarter", "PHA", "Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation, implementation of P.L. 112-144, medical device pricing and tax issues (including gag clauses), and preserving access to group purchasing organizations (GPOs);  drug compounding bills (S.959, H.R.2090, H.R.3204); 340b HRSA guidance on the GPO exclusion (HRSA Release 2013-1); FDA mobile health guidance (FDA-2011-D-0530); andtrack and trace bills (S.957 &H.R.1919).", "Centers For Medicare and Medicaid Services (CMS),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),SENATE,White House Office", null, 270000, 0, 0, "2013-10-14T14:39:55.730000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1441929"], "units": {}, "query_ms": 0.3539529861882329, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}